Thomas J
Fortschr Med. 1979 May 3;97(17):831-4.
The author reports about the treatment of 393 bacterial urinary tract infections with TMP/SMZ. It is shown that the success of treatment significantly depends on the constitution of the efferent urinary passages (obstructive and non-obstructive alterations, unchanged urinary passages) and the kind of organisms but only insignificantly on the duration of treatment. The germinal spectrum and the number of resistant strains of the individual kinds of organisms correspond with the results of other investigators. TMP/SMZ is a very potent antibiotic drug against the most pathogenic urinary organisms at a low rate of side effects.
作者报告了用复方新诺明治疗393例细菌性尿路感染的情况。结果表明,治疗的成功与否很大程度上取决于尿路输出通道的结构(梗阻性和非梗阻性改变、尿路正常)以及病原体的种类,而与治疗持续时间的关系不大。各种病原体的菌谱和耐药菌株数量与其他研究者的结果相符。复方新诺明是一种对大多数致病性尿路病原体非常有效的抗生素药物,副作用发生率较低。